Cargando…
A Potential Chinese Medicine Granule Suppressing ARDS of COVID-19: Keguan-1
Autores principales: | Zhong, Nan-shan, Yang, Zi-feng, Jiang, Mei, Liang, Jing-yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533665/ https://www.ncbi.nlm.nih.gov/pubmed/33017033 http://dx.doi.org/10.1007/s11655-020-3437-4 |
Ejemplares similares
-
Metabolomics coupled with network pharmacology study on the protective effect of Keguan-1 granules in LPS-induced acute lung injury
por: Chen, Shuaishuai, et al.
Publicado: (2022) -
Inhibitory effects and mechanisms of the anti-covid-19 traditional Chinese prescription, Keguan-1, on acute lung injury
por: Bai, Zhaofang, et al.
Publicado: (2022) -
An Overview of the Randomized Placebo-Controlled Trials of Chinese Herbal Medicine Formula Granules
por: Han, Mei, et al.
Publicado: (2019) -
The multiple sclerosis (MS) drugs as a potential treatment of ARDS in COVID-19 patients
por: Kloc, Malgorzata, et al.
Publicado: (2020) -
Lung biopsy in ARDS: is it worth the risk?
por: Malhotra, Atul, et al.
Publicado: (2006)